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ABSTRACT This study was undertaken to investigate the kinetics and molecular requirements of platelet binding to tumor
cells in bulk suspensions subjected to a uniform linear shear field, using a human colon adenocarcinoma cell line (LS174T)
as a model. The effects of shear rate (20–1000 s1), shear exposure time (30–300 s), shear stress (at constant shear rate by
adjusting the viscosity of the medium from 1.3–2.6 cP), cell concentration, and platelet activation on platelet-LS174T
heteroaggregation were assessed. The results indicate that hydrodynamic shear-induced collisions augment platelet-LS174T
binding, which is further potentiated by thrombin/GPRP-NH2. Peak adhesion efficiency occurs at low shear and decreases
with increasing shear. Intercellular contact duration is the predominant factor limiting heteroaggregation at shear rates up to
200 s1, whereas these interactions become shear stress-sensitive at 400 s1. Heteroaggregation increases with platelet
concentration due to an elevation of the intercellular collision frequency, whereas adhesion efficiency remains nearly constant.
Moreover, hydrodynamic shear affects the receptor specificity of activation-dependent platelet binding to LS174T cells, as
evidenced by the transition from a P-selectin-independent/Arg-Gly-Asp (RGD)-dependent process at 100 s1 to a P-selectin/
IIb3-dependent interaction at 800 s
1. This study demonstrates that platelet activation and a fluid-mechanical environment
representative of the vasculature affect platelet-tumor cell adhesive interactions pertinent to the process of blood-borne
metastasis.
INTRODUCTION
Blood-borne metastasis is a highly coordinated, multistep
process in which cancerous cells separate from the primary
tumor tissue and enter the circulatory system where they
interact extensively with various host cells before they
lodge in the target organ and form secondary metastatic
colonies. Accumulating evidence suggests that the ability of
tumor cells to metastasize hematogenously is regulated by
their interactions with blood platelets. The most compelling
evidence is the inhibition of metastasis by platelet depletion,
and the restoration of metastatic potential after platelet
repletion (Gasic et al., 1968; Karpatkin et al., 1988). Prior
work suggests that platelets, by attaching to tumor cells,
provide a protective shield against the cytotoxic activity of
immune cells (Honn et al., 1992; Nieswandt et al., 1999).
Moreover, platelets may assist the escape of tumor cells
from the harsh environment of the vasculature by potenti-
ating tumor cell adhesive interactions with the vessel wall
(Felding-Habermann et al., 1996). Alternatively, activated
platelets may contribute to tumor-induced angiogenesis by
secreting potent angiogenic factors (Pinedo et al., 1998).
Thus, understanding the molecular interactions between
platelets and tumor cells may provide insights ultimately
leading to the development of novel therapeutic strategies to
combat metastasis.
Published data indicate that tumor cell recruitment to
surface-anchored, activated platelets primarily occurs via a
two-step, sequential process of adhesive interactions under
dynamic flow conditions (McCarty et al., 2000). In partic-
ular, platelet P-selectin is requisite for the efficient tethering
and rolling of free-flowing colon carcinoma cells in shear
flow, presumably because of its rapid binding kinetics
(Smith et al., 1999). Transient P-selectin-mediated binding
increases the duration of cell-cell contact, thereby allowing
platelet IIb3 integrins to engage and convert these tether-
ing/rolling interactions into firm adhesion. Integrin binding
kinetics appears to preclude the formation of adhesive
bonds at high shear and corresponding short collision du-
rations in the absence of any selectin contribution due to
relatively slow rates of bond formation (Huber et al., 1995;
Springer, 1995).
The in vitro model in which tumor cells interact with
surface-adherent platelets (Karpatkin et al., 1988; McCarty
et al., 2000; Nierodzik et al., 1995) simulates events that
take place at sites of vascular injury, in which platelet
deposition to denuded endothelial cell surfaces had oc-
curred. However, tumor cells are more likely to interact
with free-flowing platelets throughout the vascular system
rather than with isolated sites of platelet deposition. The
fundamental physical and molecular requirements of tumor
cell binding to either resting or activated platelets in free-
cell suspensions as opposed to immobilized, activated plate-
let substrates remain largely obscure. Although available
evidence suggests that in the absence of flow activated
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platelets attach to tumor cells more extensively than do
resting platelets (Mannori et al., 1995; Stone and Wagner,
1993), no quantitative comparisons have been reported un-
der well-defined hydrodynamic shear conditions. Neverthe-
less, platelet-tumor cell binding typically occurs in the pres-
ence of shear flow that can critically affect the kinetics and
receptor specificity of these heterotypic adhesive interac-
tions. As has been appropriately argued in the literature,
data obtained in vitro using static binding assays may not be
relevant to the fluid flow conditions prevailing in the vas-
culature (Konstantopoulos et al., 1998a; Springer, 1995).
Consequently, this study was undertaken to characterize the
molecular interactions of tumor cells and platelets sus-
pended in plasma as a function of the dynamic shear envi-
ronment using a human colon carcinoma cell model, be-
cause colon cancer is among those tumors with a propensity
for hematogenous spread. More specifically, the LS174T
human colon adenocarcinoma cell line was chosen because
it has been extensively characterized and widely used in a
number of diverse assays (Capon et al., 1997; Jadhav et al.,
2001; Mannori et al., 1995; McCarty et al., 2000).
This study focuses on elucidating the dynamics and mo-
lecular constituents of platelet-tumor cell heteroaggregation
in a uniform shear field applied by the use of a cone-and-
plate rheometer, and analyzed by a dual-color flow cyto-
metric methodology. In particular, we wished to investigate
the influence of intercellular contact duration, applied force
among colliding cells, collision frequency, and activation-
dependent expression of platelet receptors on platelet-
LS174T cell heteroaggregation. To this end, the following
experimental parameters were systematically varied: shear
rate (20–1000 s1), shear exposure time (30–300 s), shear
stress (at constant shear rate by adjusting the viscosity of the
medium from 1.3–2.6 cP), cell concentration (25:1–200:1
platelet to LS174T ratio at a constant tumor cell concentra-
tion of 106 per mL), and platelet activation. Experimental
data were analyzed using a mathematical model based on
Smoluchowski’s two body collision theory that yields nu-
merical estimates of capture efficiency, an index that re-
flects the binding affinity of interacting cells (Hentzen et al.,
2000; Laurenzi and Diamond, 1999).
MATERIALS AND METHODS
Reagents and monoclonal antibodies
The IgG murine monoclonal antibody (mAb) SZ2 (function-blocking anti-
CD42b (anti-glycoprotein (GP) Ib)) was purchased from Beckman Coulter
(Fullerton, CA). The mAb Beb1 (anti-CD42a conjugated with fluorescein
isothiocyanate (FITC); anti-GPIX-FITC), AK4 (anti-CD62P (anti-P-selec-
tin) conjugated with phycoerythrin (PE)) and MOPC-21 (an irrelevant
control IgG antibody conjugated with either FITC or PE) were from
BD-Pharmingen (San Diego, CA). An anti-P-/E-selectin mAb EP5C7 was
generously provided by Dr. Cary L. Queen (Protein Design Labs, Fremont,
CA). The Fab anti-IIb3 mAb c7E3 was from Centocor (Malvern, PA).
The antihuman fibrin mAb MH-1 was generously provided by Dr. James
McLinden (American Biogenetic Sciences, Inc., Copiague, NY). The non-
peptide small-molecule platelet IIb3 antagonist XV454 (Abulencia et al.,
2001) was a kind gift of Dr. Shaker A. Mousa (DuPont Pharmaceuticals
Co, Wilmington, DE). The synthetic peptide Gly-Arg-Gly-Glu-Ser-Pro
(GRGESP) was from Life Technologies (Rockville, MD). The Gly-Arg-
Gly-Asp-Ser-Pro (GRGDSP) peptide, fibrin polymerization inhibitor Gly-
Pro-Arg-Pro-amide (GPRP-NH2), thrombin, prostaglandin E1 (PGE1),
trypsin (type III), isotype matched IgG mAbs, and a Fluoro FITC Conju-
gation Kit, which was used to conjugate c7E3 with FITC, were from Sigma
(St. Louis, MO). The CellTracker CMTMR (5-(and-6)-(((4-chloromethyl)-
benzoyl)amino)tetramethylrhodamine) was purchased from Molecular
Probes (Eugene, OR).
Cell line culture and staining
LS174T human colon adenocarcinoma cells were obtained from the Amer-
ican Type Culture Collection (Manassas, VA), and cultured in the recom-
mended medium. Cells were detached from culture flasks by mild
trypsinization (0.25% trypsin/EDTA for 2 min at 37°C; Life Technologies)
and subsequently incubated at 37°C for 2.5 h to regenerate surface glyco-
proteins, as previously described (Mannori et al., 1995; McCarty et al.,
2000). During this time, the carcinoma cell suspensions (107 cells/mL)
were incubated with 0.5 M CMTMR for 60 min at 37°C. LS174T cells
were then washed once to remove excess dye, and resuspended in media
for an additional 30-min interval to ensure complete modification of the
probe. After a second washing step, LS174T cells were resuspended in
Dulbecco’s phosphate-buffered saline containing Ca2/Mg2, and stored
at 4°C for no longer than 4 h before use in aggregation assays or flow
cytometry. LS174T cell viability was 97% as assessed by trypan blue
exclusion.
Platelet preparation
Human blood was drawn by venipuncture from healthy volunteers, a
patient with Glanzmann thrombasthenia (GT) (McCarty et al., 2000), and
a patient with Bernard-Soulier syndrome (BSS) (Peng et al., 1991) into
sodium citrate (0.38% wt/v) anticoagulant. In selected experiments, ci-
trated blood was treated with either 2 M PGE1 or 5 mM EDTA imme-
diately after venipuncture (Konstantopoulos et al., 1998b). Platelet-rich
plasma (PRP) was prepared by centrifugation of whole blood at 160  g
for 15 min. However, in the case of the BSS patient, PRP was obtained by
allowing whole blood to gravity separate for 2 h postvenipuncture. Platelet-
poor plasma was obtained by further centrifugation of the blood at 1900 
g for 15 min. The final platelet count of the PRP was adjusted to the desired
levels with platelet-poor plasma. Specimens were stored at room temper-
ature (RT) in capped polypropylene tubes and used within 2 h of isolation.
For some studies, the PRP viscosity (1.3 cP at 37°C) was adjusted to 2.6
cP by the addition of polymorphonuclear (PMN) leukocyte isolation me-
dium (Robbins Scientific Corporation, Sunnyvale, CA). The latter neither
affected the viability of LS174T cells as evidenced by the trypan blue
exclusion assay, nor significantly increased the osmolarity of the suspen-
sion (data not shown). Moreover, it did not alter surface-receptor expres-
sion on either platelets (e.g., P-selectin or IIb3) or LS174T colon carci-
noma cells (data not shown).
Cone-and-plate rheometry assays
Platelet and CMTMR-stained LS174T colon carcinoma cell suspensions
were allowed to equilibrate separately to 37°C for 2 min. Thereafter, 50 L
of LS174T cells (1  107 cells/mL) along with 450 L of PRP (0.28 
108 to2.22 108 platelets/mL) were placed onto the stationary platen of
a cone-and-plate rheometer (RS150; Haake, Paramus, NJ) to achieve the
desired ratio of platelets to LS174T cells (ranging from 25:1–200:1). Shear
rates varied from 20 s1 to 1000 s1 (typical of microcirculation) for
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prescribed periods of time ranging from 30 to 300 s. Static conditions were
achieved by setting the shear rate to 0 s1. The 0.5° cone and plate of the
rheometer were maintained at 37°C during the entire experiment. Upon
termination of shear, samples were obtained by pipette and instantly fixed
with 1% formaldehyde. Immediately thereafter, specimens were allowed to
incubate with a FITC-labeled platelet-specific mAb directed against either
platelet IIb3 (5 g/mL c7E3-FITC) or GPIX (0.9 g/mL anti-CD42a-
FITC) for 30 min in the dark at RT. The labeling reaction was then stopped
by further dilution with 1% formaldehyde, and specimens were subse-
quently analyzed in a FACSCalibur flow cytometer (Becton Dickinson,
San Jose, CA).
Cell treatment with thrombin, mAbs,
and enzymes
To potentiate platelet activation, PRP specimens were incubated for 10 min
before shear exposure with thrombin (0.25 or 2 units/mL) in the presence
of the fibrin polymerization inhibitor GPRP-NH2 (2 mM). In selected
experiments, platelet suspensions were treated with GPRP-NH2 alone. The
inclusion of GPRP-NH2 prevented not only fibrin polymerization but also
the formation of homotypic platelet aggregates, even after the exposure of
specimens to thrombin and/or relatively high shear rates up to 1000 s1
(data not shown).
For inhibition studies, platelets were pretreated for 10 min with EP5C7
(50 g/mL), XV454 (100 nM), c7E3 (20 g/mL), SZ2 (20 g/mL),
GRGDSP (20 mM), or Gly-Arg-Gly-Glu-Ser-Pro (20 mM), which were
kept present during the aggregation assays. Alternatively, LS174T cells
were treated with 0.25% trypsin (type III)/5 mM EDTA for 60 min at 37°C,
to remove protease-sensitive glycoproteins. After trypsin treatment,
LS174T cells were washed once and used in rheometric assays. In parallel,
control experiments were performed in which platelets and tumor cells
were treated exactly as stated above but in the absence of any function-
blocking mAb or enzyme. Platelet-colon carcinoma cell adhesive interac-
tions in response to hydrodynamic shear were unaltered by the presence or
absence of an IgG control mAb (data not shown).
Quantitation of aggregation
The particle distribution and cellular composition of stable aggregates
generated in the rheometric assay were determined by a dual-color flow
cytometric methodology. CMTMR-stained LS174T cells and FITC-labeled
platelets were identified on the basis of their characteristic forward-scatter,
side-scatter, and fluorescence profiles in a FACSCalibur flow cytometer.
FITC and CMTMR are excited efficiently at 488 nm by the argon laser of
a flow cytometer, and their emission spectra are well separated (515 nm for
FITC and 570 nm for CMTMR), thereby allowing simultaneous two-color
immunofluorescence measurements. Electronic compensation was used to
remove spectral overlap between the two fluorescent populations. Acqui-
sition and processing of 3000 CMTMR-stained LS174T cell events was
then used to determine 1) the percent of platelet-LS174T cell heteroaggre-
gation and 2) the population distribution of bound platelets to the tumor
cell surface (Fig. 1). The FITC-autofluorescence of the LS174T cell
population was used to set a threshold (Fig. 1, vertical line) that separates
nonadherent single LS174T cells from those bound to platelets. Therefore,
the percentage of tumor cells expressing a green fluorescence above this
background threshold corresponds to the percentage of LS174T cells
binding FITC-labeled platelets.
The following strategy was adapted to determine the number of bound
platelets per tumor cell from the flow cytometric measurements (Fig. 1).
The mean and standard deviation of single platelet FITC-fluorescence
intensity were computed. Six times the calculated standard deviation pro-
vides the range of a single platelet fluorescent event with a 99% confi-
dence. This range was then superimposed to the computed threshold value
of LS174T cell green fluorescence, thereby characterizing the limiting
values for a single platelet-tumor cell event (P1T1). Using this methodol-
ogy, heterotypic platelet-tumor cell aggregates comprised of a single
LS174T cell with one (P1T1), two (P2T1), three (P3T1), or more (P4T1)
adherent platelets were detected and enumerated (Fig. 1). Aggregates
consisting of four or more platelets were rare events representing 1% to
3% of the total LS174T cell population and were therefore grouped into the
(P4T1) category. Using this methodology, differences in the fluorescence
intensity of the platelet label between individual experiments did not affect
the percentage of platelet-tumor cell aggregates nor the population distri-
bution of heteroaggregates. Under the experimental conditions of this
study, homotypic platelet aggregation was negligible with less than 5% of
platelets in aggregates even under the most extreme conditions reported
here (data not shown).
Determination of adhesion efficiency of platelet
binding to LS174T colon carcinoma cells
Platelet-LS174T heteroaggregation in response to hydrodynamic shear
exposure is determined by the intercellular collision frequency and the
capture efficiency of these collisions. The two-body collision frequency per
unit volume, f[(i,j),(m,n)], is a function of the physical parameters of the
experimental system, and can be calculated by the Smoluchowski equation:
f[(i,j),(m,n)]
4
3
ri, j rm, n3Ci, jCm, nG (1)
in which r(i, j) and r(m, n) are radii of the two colliding particles, one
composed of i platelet  j LS174T singlets and other one comprised of m
platelet  n LS174T singlets, C(i, j) and C(m, n) are their respective
concentrations, and G is the shear rate. The radius of a single LS174T cell
was calculated to be 6.0 m by image processing, whereas the correspond-
ing one for a platelet singlet was set to 1.34 m (Laurenzi and Diamond,
1999; Tandon and Diamond, 1997).
Platelet-LS174T cell adhesion efficiency (EPT) is defined as the fraction
of heterotypic shear-induced collisions that result in stable heteroaggregate
formation. This index is a function of the intrinsic biological characteristics
of the cells that are pertinent to their aggregation behavior such as number
and affinity of receptors and their response to applied shear (Hentzen et al.,
2000; Huang and Hellums, 1993). The adhesion efficiency of platelet
binding to LS174T cells can be calculated by fitting the aggregation data
over the first 60 s after application of shear with a mathematical model
based on Smoluchowski’s two-body collision theory (Hentzen et al., 2000).
This model (Eq. 2) describes the temporal change of the concentrations of
aggregates C(m, n) composed of m platelet and n LS174T cell singlets in
the most general case (Laurenzi and Diamond 1999):
dCm, n
dt
 
i	0
m 
j	0
n 12 1 	i,mi	j,nj

 K[(i,j),(mi,nj)]Ci, jCm i, n j
 
i	m
m max 
j	n
n max

1 	m,im	n,jn

 K[(m,n),(im,jn)]Cm, nCi m, j n
(2)
in which K[(i,j),(m,n)] is the aggregation rate coefficient, 	i, j is Kronecker
delta function, mmax and nmax represent the maximal number of platelets
and tumor cells in an aggregate, respectively, used in the simulation. mmax
was set equal to four due to the fact that heteroaggregates comprised of a
single LS174T cell with more than four adherent platelets were rather rare
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events (Fig. 1), and thus, grouped into the P4T1 category. nmax was set to
one due to the observation that LS174T cells do not aggregate with each
other under the experimental conditions tested in this study. The first term
in the right-hand-side of Eq. 2 accounts for the formation of the combi-
FIGURE 1 Detection of platelet-tumor cell aggregates by flow cytom-
etry and electron microscopy. Platelets (5  107 cells/mL) and CMTMR-
stained LS174T cells (1  106 cells/mL) were subjected to either 0 s1 or
100 s1 for 120 s at 37°C. Upon termination of shear, aliquots were
immediately fixed with 1% formaldehyde, postlabeled with an FITC plate-
let-specific antibody (c7E3-FITC), and subsequently analyzed by a dual-
color flow cytometric technique. (A) Unsheared platelet-tumor cell speci-
men after 120 s showing single LS174T cells with and without adherent
platelets. (B) Platelet-tumor cell specimen subjected to shear for 120 s at
100 s1. The vertical line in A and B corresponds to the FITC-fluorescence
threshold that separates nonadherent LS174T cells (left) from those bound
to platelets (right). Mean platelet fluorescence histograms of C unsheared
and D sheared platelet-LS174T cell specimens, corresponding to the data
in A and B. T, P1T, P2T, P3T, P4T represent LS174T cells binding zero,
one, two, three, and four or more platelets, respectively. (E) Electron
micrographs showing (from left to right) heterotypic aggregates composed
of a single LS174T cell and one or two platelets (4900; scale bar 	 2
m).
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nation from two smaller aggregates, whereas the second term represents the
depletion of the combination due to the formation of a higher order
aggregate. Because our goal is to measure the initial rate of recruitment of
platelets and tumor cells into heterotypic aggregates, the terms describing
the fragmentation process have been neglected. Furthermore, heterotypic
platelet-LS174T cell aggregates once formed were stable over a wide range
of shear stresses for at least 5 min, which corresponds to the longest shear
exposure time used in this study.
The set of coupled differential equations represented by Eq. 2 was
integrated using the fourth order Runge-Kutta-Gill method and the adhe-
sion efficiency (EPT), defined by Eq. 3, was calculated by using the Golden
Section Search Method (Belegundu and Chandrupatla 1999):
EPT
K[(1,0),(m,1)]C1, 0Cm, 1
f[(1,0),(m,1)]
(3)
in which K[(1,0), (m, 1)] is the aggregation rate coefficient that describes the
adhesion kinetics when a platelet singlet adheres to a particle comprised of
m platelet 1 LS174T cell singlets. The aforementioned model is based on
the following key assumptions: 1) single cells and aggregates have spher-
ical geometries; 2) only single collisions between any two particles are
considered at a given time; 3) homotypic platelet and LS174T cell aggre-
gation are absent, and hence, only single platelet binding to either an
LS174T cell singlet or an LS174T-platelet aggregate are considered (Fig.
1 E).
Quantitation of P-selectin and platelet-bound
fibrin expression
PRP specimens, preincubated with thrombin/GPRP-NH2, GPRP-NH2
alone, or buffer for 10 min, were subjected to hydrodynamic shear (0, 100,
or 800 s1) for 60 s in the presence or absence of LS174T cells. Upon
termination of shear, specimens were fixed with 1% formaldehyde and
incubated with a PE-labeled anti-P-selectin mAb, AK4-PE, for 30 min at
RT. Thereafter, specimens were diluted with fixative and analyzed in a
FACSCalibur flow cytometer. Results were expressed as the percentage of
platelets expressing PE fluorescence above the background as previously
described (Konstantopoulos et al., 1998b).
To assess the extent of platelet-bound fibrin, PRP specimens pretreated
with either thrombin/GPRP-NH2, GPRP-NH2 alone, or buffer for 10 min
were fixed with 1% formalin (Richard Allan Scientific, Kalamazoo, MI)
and washed twice with Dulbecco’s phosphate-buffered saline to remove
soluble fibrin. After a 15-min incubation with the antihuman fibrin mAb
MH-1 (40 g/mL), platelets were washed once, incubated for additional 15
min with PE-labeled IgG antibody (15 g/mL), washed again, and ana-
lyzed in a FACSCalibur flow cytometer (Konstantopoulos et al., 1997;
McCarty et al., 2000). An appropriate isotype-matched IgG mAb was also
included for background fluorescence determination.
Electron microscopy
Samples containing platelet-tumor cell aggregates were prepared for elec-
tron microscopy by standard procedures. Briefly, sheared specimens were
fixed in 1.5% glutaraldehyde for 1 h at RT and postfixed for 1 h in Palade’s
1% osmium tetroxide at 4°C, and subsequently incubated in Kellenberger’s
uranyl acetate solution overnight. After dehydration with a graded series of
ethanol, cells were embedded in Epon. After polymerization, ultrathin
sections were obtained on a Leica Ultracut UCT microtome equipped with
a diamond knife. Sections were then stained with uranyl acetate and lead
citrate before viewing with an electron microscope (Phillips 420 TEM).
Statistics
Data are expressed as the mean  SE unless otherwise stated. Statistical
significance of differences between means was determined by analysis of
variance. If means were shown to be significantly different, multiple
comparisons by pairs were performed by the Tukey test. Probability values
of p  0.05 were selected to be statistically significant.
RESULTS
Hydrodynamic shear-induced collisions support
formation of platelet-LS174T cell aggregates
Previous studies have shown that platelets bind to various
carcinoma cells including the colon adenocarcinoma
LS174T cell line under static conditions (Karpatkin et al.,
1988; Mannori et al., 1995; Nierodzik et al., 1995). To
investigate how the hydrodynamic shear environment of the
circulation modulates these heterotypic adhesive interac-
tions, LS174T cells were combined with platelets sus-
pended in plasma in a cone-and-plate rheometer and sub-
jected to controlled levels of shear for defined periods of
time. A ratio of 50 platelets (5  107 cells/mL) to one
LS174T cell (1  106 cells/mL) was maintained in all
shearing experiments, unless otherwise stated. Under these
conditions, platelet-platelet aggregation was minimal with
only l% to 5% of platelets in homotypic aggregates. In
contrast, extensive aggregation and large platelet aggre-
gates, comparable in size with an LS174T cell, were con-
sistently observed when higher platelet concentrations
mixed with LS174T cells were subjected to elevated levels
of shear (100 s1) for relatively long shear exposure times
(60 s) (data not shown). Under the experimental condi-
tions of this study, LS174T cells did not homotypically
aggregate.
A baseline level of platelet-LS174T cell binding (9.3 
1.0% LS174T cells in heteroaggregates, n 	 4) was de-
tected under static conditions at 30 s (Fig. 2 A). Further-
more, the extent of heteroaggregation varied little with time
at 0 s1 (11.6  0.9% LS174T cells in heteroaggregates
after 120 s of static incubation, n	 6) (Figs. 1, A and C, and
2 A). Application of shear in the absence of any exog-
enously added chemical agonist augmented platelet-
LS174T heterotypic aggregation, as determined by the in-
crease in LS174T-bound platelet fluorescence (Fig. 1, B and
D). The extent of platelet recruitment by LS174T cells
increased with increasing shear exposure time over a wide
range of shear rates (Fig. 2 A), plateaued at 120 s, and
remained irreversible for at least 300 s. For example, 30.0
1.9%, 28.9  1.5%, and 29.4  4.0% of LS174T cells had
platelets adherent to their surface after 120, 180, and 300 s
of shear exposure at 100 s1, respectively. Similar results
were obtained at all other shear rates (data not shown).
Platelet binding to LS174T cells increased with shear rate
from baseline levels under static conditions (0 s1) to a
maximum at 100 s1. However, at shear rates above 100
s1, the extent of heteroaggregation decreased with increas-
ing shear. The majority (85%) of platelet-LS174T cell
aggregates were present as single tumor cells with one or
two platelets bound to their surface (Fig. 1) as confirmed by
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both transmission electron microscopy (Fig. 1 E) and light
microscopy (data not shown). Flow cytometric analysis of
sheared specimens reveals that 3% of LS174T cells had
four or more platelets adherent to their surface.
The recruitment of platelets by LS174T cells was signif-
icantly potentiated over a wide range of shear rates upon
incubation of platelets with thrombin and the fibrin poly-
merization inhibitor, GPRP-NH2 (Fig. 2 B). For instance,
the percentage of LS174T cells with platelets adherent to
their surface increased from 24% to 36% in the presence
of thrombin/GPRP-NH2 (0.25 units/mL; 2 mM) after 60 s of
shear exposure at 100 s1 (Fig. 2 B, Table 1). Treatment of
platelets with thrombin/GPRP-NH2 increased both plate-
let-bound fibrin and platelet P-selectin expression levels
in a concentration-dependent fashion (Table 1). More-
over, thrombin/GPRP-NH2 stimulation augmented the
extent of platelet-LS74T cell binding in a dose-dependent
manner only at high (800 s1) but not low (100 s1)
levels of shear (Table 1). Treating specimens with GPRP-
NH2 alone appeared to slightly increase heteroaggrega-
tion only at low shear rates (Table 1), which was more
evident at longer shear exposure times (120 s) (data not
shown).
The efficiency of platelet capture by LS174T cells pro-
vides a measure of the biological properties of the cells that
control their aggregation behavior, and was computed by
fitting the aggregation data over the first 60 s after applica-
tion of shear (Hentzen et al., 2000). Fig. 2 C shows the shear
rate dependence of adhesion efficiency in the presence and
absence of thrombin/GPRP-NH2 (0.25 units/mL; 2 mM).
Maximal efficiency in the absence of any exogenously-
added chemical agonist was observed at the lowest shear, at
which 2 to 3 of 1000 collisions led to stable platelet-
LS174T aggregate formation (Fig. 2 C), and decreased with
increasing shear. A similar efficiency versus shear rate
pattern was also noted after platelet treatment with throm-
bin/GPRP-NH2 (0.25 units/mL; 2 mM), and was signifi-
cantly enhanced over untreated platelets at shear rates rang-
ing from 50 to 800 s1 (Fig. 2 C). A further increase in
adhesion efficiency was observed at high shear (800 s1)
with increasing thrombin concentration (no-treatment:
0.082  0.01  103 versus 0.25 units/mL thrombin/2 mM
GPRP-NH2: 0.18  0.01  10
3 versus 2 units/mL throm-
bin/2 mM GPRP-NH2: 0.27  0.03  10
3; mean  SE,
n	 3–4). In contrast, an increase in thrombin concentration
from 0.25 units/mL to 2 units/mL did not significantly
affect the adhesion efficiency at low shear (100 s1) con-
ditions (data not shown).
Effects of shear rate versus shear stress on
platelet-LS174T cell aggregate formation
We next wished to examine the effects of hydrodynamic
shear rate not only on the formation of heterotypic aggre-
gates but also on the strength of adhesion by subjecting
platelet-LS174T cell suspensions to well-defined levels of
FIGURE 2 Kinetics of platelet-LS174T cell aggregate formation. (A) Ef-
fects of hydrodynamic shear on platelet-LS174T cell binding in the absence of
any exogenously added chemical agonist. Platelets (5  107 cells/mL) were
combined with CMTMR-stained LS174T cells (1  106 cells/mL) in the
cone-and-plate rheometer and subjected to well-defined levels of shear for 30 s
(‚), 60 s (), or 120 s (E). Data represent the percentage of LS174T cells
with bound platelets. *p  0.05 with respect to 30 s. §p  0.1 with respect to
120 and 30 s. Data represent mean  SE of 3 to 18 experiments. (B) Effects
of hydrodynamic shear on platelet-LS174T cell binding in the presence and
absence of thrombin and GPRP-NH2. Platelets (5  10
7 cells/mL), pretreated
for 10 min with () or without () fibrin polymerization inhibitor (2 mM
GPRP-NH2) and thrombin (0.25 units/mL), were combined with CMTMR-
stained LS174T cells (1  106 cells/mL) before the application of shear for
60 s. (C) Adhesion efficiency of platelet binding to LS174T cells as a function
of hydrodynamic shear in the presence and absence of thrombin and GPRP-
NH2. *p 0.05 with respect to no-treatment shear. Data represent mean SE
of three to nine experiments.
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shear. Application of low shear (100 s1) for both 60 (Fig.
3 Ab) and 120 s (Fig. 3 Ac) led to increased platelet-tumor
cell binding compared with either static (Fig. 3 Aa) or high
shear (1000 s1) conditions (Fig. 3 Ad, e). The integrity of
the platelet-LS174T aggregate formed under low shear was
preserved when exposed to subsequent high shear for 60 s
(Fig. 3 Af), thus suggesting that heteroaggregates, once
formed, are resistant to disaggregation with increasing
shear. In contrast, platelets and LS174T cells subjected to
high shear for 60 or 120 s did not aggregate. However, they
retain the ability to form heterotypic aggregates upon sub-
sequent exposure to low shear for 60 s (Fig. 3 Ag). Similar
results were obtained in the presence of thrombin/GPRP-
NH2 (data not shown).
Consequently, the increased heteroaggregation observed
at low shear rates might be attributed to either the longer
intercellular contact time and/or the lower net force acting
on the cells. By separately varying the viscosity of the
medium and the hydrodynamic shear rate, the contributions
of contact duration and shear stress could be differentiated
(Hentzen et al., 2000; Rinker et al., 2001). To this end, 20%
PMN media was used to increase the viscosity of the sus-
pending medium from 1.3 to 2.6 cP at 37°C, thereby in-
creasing shear stress at a constant shear rate, while main-
taining the same contact time. Platelets treated with
thrombin/GPRP-NH2 (0.25 units/mL; 2 mM) before their
mixing with LS174T cells and application of shear were
used to produce significant heteroaggregation in the absence
of platelet-platelet cohesion induced by elevated shear stress
in the presence of PMN media. Fig. 3 B shows that under
low shear (200 s1), platelet-LS174T cell binding was
essentially independent of the viscosity of the medium.
However, at higher shear rates (400 s1), the increase in
shear stress due to an increase in viscosity significantly
decreased the extent of heteroaggregation. In accordance,
heterotypic adhesion efficiency decreases with shear stress
at higher shear rates (Table 2).
Dependence of platelet-LS174T
heteroaggregation on platelet concentration
We next wanted to investigate the effects of platelet con-
centration on the extent of platelet-LS174T heteroaggrega-
tion. To this end, we systematically varied the platelet
concentration from 2.5  107 to 20  107 platelets/mL,
whereas the LS174T cell concentration (1  106 cells/mL)
remained constant, thereby modulating the platelet to
LS174T cell ratio from 25:1 to 200:1. To achieve significant
heteroaggregation at lower platelet counts and to prevent
potential platelet-platelet aggregation at higher platelet con-
centrations, platelets were treated with thrombin/GPRP-
NH2 (0.25 units/mL; 2 mM) before their mixing with
LS174T cells and application of shear. Fig. 4 A shows that
heterotypic platelet-LS174T cell aggregation increased with
increasing platelet concentration under both static and shear
(100 s1) conditions. Moreover, peak heteroaggregation
occurred at near physiological platelet concentrations (20
107 platelets/mL). However, corresponding adhesion effi-
ciencies varied little over the broad range of platelet con-
centrations tested in this study. Over an eightfold increase in
platelet concentration, the adhesion efficiency reduced
moderately by only one-fifth, from 1.37  103 at 25:1
platelet to LS174T cell ratio to 1.07  103 at 200:1 ratio.
Roles of platelet P-selectin and IIb3-integrins in
platelet-LS174T cell heteroaggregation at high
and low shear
Ensuing experiments focused on the elucidation of the mo-
lecular pathways mediating platelet binding to LS174T cells
under dynamic shear conditions. Prior work has shown that
both platelet P-selectin and IIb3-integrins are required to
support optimal LS174T cell adhesive interactions with
immobilized, activated platelets under shear (McCarty et
al., 2000). Therefore, as a first step, the roles of these
platelet receptors were examined in the high shear regime,
TABLE 1 Effects of thrombin and fibrin polymerization inhibitor GPRP-NH2
Platelet treatment Platelet-bound fibrin P-selectin expression (%)
% of LS174T cell heteroaggregation
100 sec1 800 sec1
— 3.1  0.9 5.5  0.4 23.6  0.2 14.7 0.9
GPRP-NH2 3.4  1.4 6.6  0.8 25.9  0.4 14.8  0.5
0.25 units/mL Thr  GPRP-NH2 29.4  3.7* 7.7  0.9* 36.5  2.8* 20.5  1.1*
2 units/mL Thr  GPRP-NH2 89.8  7.0*
§ 92.7  3.2*§ 34.7  4.0* 33.9  1.7*§
Platelets (5  107 cells/mL), either untreated (control) or pretreated for 10 min with fibrin polymerization inhibitor (2 mM GPRP-NH2) in the absence or
presence of thrombin (0.25 or 2 units/mL), were examined for the extent of bound fibrin using an indirect single-color immunofluorescent assay. Values
represent the geometric mean fluorescence intensities mean  SE (n 	 3–4) after subtracting background fluorescence measured using an appropriate
isotype-matched IgG mAb. P-selectin expression was quantified as percentage of platelets expressing an AK4-PE (anti-P-selectin mAb conjugated with PE)
fluorescence above the background. Platelets (5  107 cells/mL) were combined with CMTMR-stained LS174T cells (1  106 cells/mL) prior to the
application of shear for 60 s at 100 and 800 s1. A dual-color flow cytometric technique was used to quantify the percentage of LS174T cells with bound
platelets. *p  0.05 with respect to no-treatment (control) specimens, §p  0.05 with respect to 0.25 units/mL thrombin-treated specimens. Data represent
mean  SE of three to six experiments.
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and in particular at a shear rate of 800 s1. The results
indicate that incubation of platelets (5  107/mL) with
either a function blocking anti-P-selectin antibody or
IIb3-integrin antagonist inhibited the extent of LS174T
cell adhesive interactions with thrombin/GPRP-NH2-treated
platelets (Fig. 5 A). A similar reduction in heteroaggregation
was also noted at the physiological platelet concentration of
20  107 platelets/mL (data not shown). Regardless of
platelet or thrombin concentration, no additive inhibitory
effect on platelet-LS174T heteroaggregation was observed
with a combination of P-selectin and IIb3-integrin antag-
onists (Fig. 5 A). Moreover, use of RGD-containing pep-
tides inhibited platelet binding to LS174T cells to a similar
degree with that observed with an IIb3 specific blocker
(data not shown).
We next wished to examine whether these molecular
recognition events are required for platelet-LS174T cell
interactions in the low shear regime (100 s1). Our results
indicate that blockade of platelet P-selectin and IIb3-
integrins, whether alone or in combination, failed to alter
the extent of recruitment of thrombin/GPRP-NH2-treated
platelets by LS174T cells, regardless of thrombin concen-
tration (Fig. 5 B).
Characterization of molecular mechanisms
mediating platelet-LS174T cell heteroaggregation
at low shear
Subsequent experiments aimed to characterize the molecu-
lar interactions between LS174T cells and platelets in re-
sponse to a low level of hydrodynamic shear (100 s1) in
the absence of any exogenously added chemical agonist. As
in the case of thrombin/GPRP-NH2-treated platelets, spe-
cific antagonists of platelet P-selectin (EP5C7) and/or
IIb3-integrins (c7E3 or XV454) did not inhibit the extent
of heterotypic platelet-LS174T cell adhesive interactions
(Fig. 6 A).
GPIb is abundantly expressed on the platelet surface
(25,000 copies per platelet), and has previously been impli-
cated in platelet-tumor cell interactions under static condi-
tions (Oleksowicz et al., 1995). We therefore, investigated
its potential contribution to platelet-LS174T heteroaggrega-
FIGURE 3 Effects of shear rate versus shear stress on platelet-LS174T
heteroaggregates. (A) Effects of hydrodynamic shear on platelet-LS174T
aggregate formation and disaggregation. Platelets (5  107 cells/mL) and
CMTMR-stained LS174T cells (1  106 cells/mL) were subjected to (a)
static conditions for 120 s, (b) 100 s1 for 60 s, (c) 100 s1 for 120 s, (d)
1000 s1 for 60 s, (e) 1000 s1 for 120 s, (f) 100 s1 for 60 s followed by
1000 s1 for 60 s, or (g) 1000 s1 for 60 s followed by 100 s1 for 60 s.
Data represent the percentage of LS174T cells in heteroaggregates. *p 
0.05 with respect to control shear and time (100 s1 for 120 s). (B) Effects
of shear stress on platelet-LS174T cell aggregate formation. Platelets (5 
107 cells/mL), pretreated for 10 min with fibrin polymerization inhibitor (2
mM GPRP-NH2), and thrombin (0.25 units/mL) were equilibrated with
(2.6 cP,) or without (1.3 cP,) PMN media at 37°C for 2 min, and then
combined with CMTMR-stained LS174Tcells (1  106 cells/mL) in the
cone-and-plate rheometer. Specimens were subjected to well-defined levels
of hydrodynamic shear for 60 s. *p  0.05 with respect to control (1.3 cP).
Data represent mean  SE of three to four experiments.
TABLE 2 Effect of shear stress at a constant shear rate on
the adhesion efficiency of platelet-LS174T binding
Shear rate
(s1)
Adhesion efficiency (103)
Medium viscosity
	 1.3 cP
Medium viscosity
	 2.6 cP
25 5.52  1.06 6.37  1.06
50 3.63  0.07 4.02  0.29
100 1.82  0.21 1.99  0.16
200 0.84  0.05 0.71  0.10
400 0.32  0.02 0.19  0.01*
800 0.18  0.01 0.10  0.01*
Platelets (5  107/mL), pretreated for 10 min with fibrin polymerization
inhibitor (2 mM GPRP-NH2) and thrombin (0.25 units/mL), were equili-
brated with (2.6 cP) or without (1.3 cP) PMN media at 37°C for 2 min, and
then combined with CMTMR-stained LS174T cells (1  106 cells/mL) in
the cone-and-plate rheometer. Specimens were subjected to defined levels
of shear rate for 60 s, and aggregation was quantified by flow cytometry.
The adhesion efficiency of heteroaggregation was calculated from exper-
imental results using a mathematical model based on Smoluchowski’s
two-body collision theory. *p  0.05 with respect to control (1.3 cP). Data
represent mean  SE of three to four experiments.
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tion using a function-blocking anti-GPIb specific antibody
(SZ2). However, this mAb failed to affect the extent of
platelet-LS174T cell binding (Fig. 6 A).
To further validate the aforementioned findings, we used
PRP specimens from a patient with GT whose platelets are
devoid of IIb3 integrins, as well as a patient with BSS
whose platelets are deficient in the GPIb-IX complex. The
results indicate that both GT and BSS platelets adhered to
LS174T cells as effectively as platelets from healthy vol-
unteers when subjected to a shear rate of 100 s1 for 120 s
(Fig. 6 B). Furthermore, the presence of specific antagonists
directed against platelet P-selectin and IIb3-integrin did
not alter the percentage of LS174T cells with bound BSS
platelets (data not shown). Taken together, our data suggest
that platelet P-selectin, IIb3-integrin, or GPIb/IX are not
likely to be involved in platelet-LS174T cell binding at low
shear.
Previous work has shown that both homotypic platelet
aggregation (Goldsmith et al., 1994) and heterotypic plate-
let-leukocyte adhesive interactions (Konstantopoulos et al.,
1998b) in response to hydrodynamic shear are dependent
upon the state of platelet activation. To assess the involve-
ment of platelet activation in the formation of platelet-
LS174T heteroaggregates, platelets were treated with PGE1
immediately after blood collection. This treatment dramat-
ically reduced the ability of platelets to form heterotypic
aggregates with LS174T cells (Fig. 6 B), suggesting that
platelet activation regulates these adhesive interactions.
Consequently, these specific adhesion events are likely to be
mediated by the activation of an array of integrins that are
present on the platelet surface. Platelet integrins bind prin-
cipally to Arg-Gly-Asp (RGD)-containing peptide se-
quences present in adhesive proteins such as fibrin(ogen)
and von Willebrand factor (Konstantopoulos et al., 1998a).
To assess the potential integrin involvement in platelet-
LS174T cell binding induced by hydrodynamic shear, plate-
lets were treated with a GRGDSP peptide before their
mixing with tumor cells and application of shear. The re-
FIGURE 4 Effects of the platelet concentration on platelet-LS174T het-
eroaggregate formation under well-defined hydrodynamic shear condi-
tions. Platelets (2.5–20  107 cells/mL), pretreated for 10 min with fibrin
polymerization inhibitor (2 mM GPRP-NH2), and thrombin (0.25 units/
mL), were combined with CMTMR-stained LS174T cells (1  106 cells/
mL) to achieve the desired tumor cell:platelet ratio (ranging from 25:1–
200:1) before the application of shear for 60 s at 100 s1. (A) Data
represent the percent of LS174T cells in heteroaggregates. (B) Adhesion
efficiency of heteroaggregation was calculated from experimental data
using a mathematical model based on Smoluchowski’s two-body collision
theory. Data represent mean  SE of three to seven experiments.
FIGURE 5 Effects of platelet P-selectin and IIb3 antagonists on plate-
let-LS174T cell heteroaggregation at (A) high and (B) low shear. Platelets
(5  107 cells/mL), pretreated for 10 min with fibrin polymerization
inhibitor (2 mM GPRP-NH2), and thrombin (0.25 units/mL or 2 units/mL)
were combined with CMTMR-stained LS174T cells (1  106 cells/mL) in
the cone-and-plate rheometer, and subjected to a shear of (A) 800 s1 or (B)
100 s1 for 60 s. In selected experiments, platelets were treated with agents
specific for P-selectin (50 g/mL EP5C7) and/or IIb3-integrin (100 nM
XV454) for 10 min before their mixing with untreated CMTMR-stained
LS174T cells. Data represent the percentage of LS174T cells in heteroag-
gregates. *§p  0.05 with respect to shear in the absence of antibodies for
treatment with 0.25 or 2 units/mL thrombin, respectively. Data represent
mean  SE of three to five experiments.
844 McCarty et al.
Biophysical Journal 83(2) 836–848
sults indicate that the RGD-containing peptide GRGDSP
inhibited the heteroaggregation between platelets and
LS174T cells to baseline levels (Fig. 6 B). Similar results
were also obtained when thrombin/GPRP-NH2-treated
platelets were sheared with LS174T cells at 100 s1 (data
not shown). In distinct contrast, a control Gly-Arg-Gly-Glu-
Ser-Pro peptide failed to affect the extent of platelet-
LS174T cell binding (data not shown).
Experiments were also performed in the presence of 5
mM EDTA added to citrate-anticoagulated blood specimens
immediately after venipuncture to assess the divalent cation
requirements in this process (Konstantopoulos et al.,
1998b). Fig. 6 B shows that the presence of EDTA in the
suspension essentially abrogates platelet-LS174T cell bind-
ing in response to hydrodynamic shear exposure. This in-
hibitory effect might be ascribed to possible elimination of
divalent cation-dependent integrin binding and/or suppres-
sion of cation-dependent platelet activation pathways (Kon-
stantopoulos et al., 1998a).
We finally aimed to characterize the LS174T cell li-
gand(s) mediating heterotypic aggregation with platelets.
Enzymatic treatment of the tumor cell surface with trypsin
drastically reduced the percentage of LS174T cells with
bound platelets. Taken together, our results indicate that
platelet-LS174T cell binding in response to hydrodynamic
shear is mediated by specific, RGD sequence dependent
interactions between the platelet surface, and protease-sen-
sitive glycoproteins on the colon carcinoma cell surface.
However, the identity of adhesion receptors mediating
platelet-LS174T heteroaggregation under low shear remains
unknown.
DISCUSSION
To the best of our knowledge, this is the first study to
analyze the kinetics and molecular requirements of platelet-
tumor cell binding in bulk suspensions as a function of the
dynamic shear environment encountered in the vasculature.
The major findings of this work are: 1) hydrodynamic
shear-induced collisions augment platelet-LS174T cell
binding in the absence of any exogenously-added chemical
agonist; 2) the capture efficiency of these heterotypic adhe-
sive interactions is regulated by the state of platelet activa-
tion and decreases with increasing shear; 3) a transition in
the molecular recognition events mediating heteroaggrega-
tion is observed with shear from an P-selectin-independent/
RGD-dependent process in the low shear regime to a P-se-
lectin/IIb3-dependent process at high shear.
Hydrodynamic shear and platelet activation
modulate the kinetics of platelet-LS174T
cell heteroaggregation
Our data indicate that platelets readily coaggregated with
LS174T cells when subjected to well-defined hydrodynamic
shear conditions in the absence of any exogenous chemical
stimulation. The efficiency of heteroaggregation varied with
both shear rate and shear stress. In particular, peak effi-
ciency was detected at low shear (20 to 50 s1), at which 2
to 3 of 1000 collisions resulted in stable heteroaggregate
FIGURE 6 Characterization of molecular mechanisms mediating plate-
let-LS174T cell heteroaggregate formation under hydrodynamic shear con-
ditions. (A) Contributions of platelet P-selectin, IIb3, and GPIb on
platelet-LS174T cell heteroaggregation at low shear (100 s1) in the
absence of any exogenously added chemical agonist. PRP (5  107
cells/mL), isolated either from healthy volunteers, a patient with GT, or a
patient with BSS, was combined with CMTMR-stained LS174T cells (1 
106 cells/mL) before the application of shear for 120 s at 100 s1. Upon
termination of shear, aliquots were immediately fixed with 1% formalde-
hyde, postlabeled with the appropriate FITC-conjugated platelet-specific
antibody (anti-GPIX-FITC or c7E3-FITC), and then analyzed by flow
cytometry. In selected experiments, platelets were pretreated with anti-P-
selectin (50 g/mL EP5C7), anti-IIb3-integrin (20 g/mL c7E3), or
anti-GPIb (20 g/mL SZ2) function-blocking antibodies. *p  0.05 with
respect to no-treatment control. Data represent mean SE (n	 three to six
healthy volunteers; n 	 1 GT patient performed in triplicate; n 	 1 BSS
patient performed in duplicate). (B) Effects of platelet activation, peptides,
and enzymes on platelet-LS174T cell aggregation. Platelets (5  107
cells/mL) and CMTMR-stained LS174T cells (1  106 cells/mL) were
sheared as described in A. In selected experiments, platelets were treated
with prostaglandin E1 (2 M PGE1), 20 mM GRGDSP peptide, or 5 mM
EDTA before the shearing experiment. Alternatively, CMTMR-stained
LS174T cells were treated with trypsin (0.25% type III trypsin). *p  0.05
with respect to no-treatment control. Data represent mean  SE of 3 to 47
experiments.
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formation. The adhesion efficiency of these interactions
reduced with increasing shear rate, reaching a basal value at
1000 s1. Comparable efficiency values have been reported
for the binding of platelets stimulated with low doses of
ADP (0.5 M) to fibrinogen-coated polystyrene beads
(Bonnefoy et al., 2000).
The adhesion efficiency of platelet-LS174T cell binding
increased over a range of shear rates from 50 to 800 s1
upon platelet treatment with thrombin/GPRP-NH2. Inclu-
sion of exogenous thrombin in the medium can stimulate
platelets (by increasing the affinity of platelet receptors
(e.g., IIb3) for their respective ligands and inducing the
release of adhesion molecules from intracellular pools onto
the cell surface (e.g., P-selectin)) and degrade plasma and
platelet-bound fibrinogen into fibrin. In distinct contrast, no
detectable heteroaggregation occurred when platelets were
pretreated with PGE1 before their mixing with LS174T cells
in a linear shear field. This compound has been shown to
elevate cAMP levels in platelets and to inhibit platelet
activation and aggregation (Hardwick et al., 1980). Taken
altogether, our data suggest that platelet activation regulates
the kinetics of platelet-LS174T cell heteroaggregation.
The efficiency of these adhesive interactions decreases
with increasing shear rate, a finding that might be ascribed
to either shorter intercellular contact durations and/or higher
forces exerted on colliding cells. The influence of contact
time and stress on platelet-LS174T cell binding was as-
sessed in thrombin (0.25 units/mL)/GPRP-NH2 (2 mM)-
treated platelets by separately adjusting the shear rate and
viscosity of the medium (Hentzen et al., 2000; Rinker et al.,
2001). Apparently, the critical parameter (intercellular con-
tact duration versus viscous forces (Chen and Springer
2001; Rinker et al., 2001; Swift et al., 1998)) affecting the
rate and extent of platelet recruitment by LS174T cells is
regulated by hydrodynamic shear environment. In particu-
lar, intercellular contact duration is the predominant factor
limiting heteroaggregation at low shear (200 s1),
whereas these interactions become shear stress sensitive in
the high shear regime (400 s1). Furthermore, heteroag-
gregates once formed are resistant to breakage when sub-
jected to high shear. This result suggests that the absence of
heteroaggregate formation at high shear (1000 s1) is at-
tributed to the inability of participating receptor-ligand
pair(s) to form adhesive bonds at short contact times rather
than to the disaggregation of formed aggregates due to their
exposure to high shear forces.
The extent of platelet-LS174T cell binding increases with
increasing platelet concentration at a constant LS174T cell
number density, presumably due to the increase of the
intercellular collision frequency. Maximal heteroaggrega-
tion was detected at near physiological platelet concentra-
tions (20  107 platelets/mL). However, the capture effi-
ciency of these interactions varied little with cell
concentration, in agreement with previous work on neutro-
phil-ICAM-1 transfectant interactions (Hentzen et al.,
2000).
Hydrodynamic shear regulates the specificity of
platelet-LS174T cell interactions
We have recently demonstrated that LS174T cell adhesion
to immobilized platelet substrates primarily occurs via a
two-step, sequential process of interactions at a wall shear
stress of 0.8 dyn/cm2 (McCarty et al., 2000). Platelet P-
selectin is essential for the optimal tethering/rolling of
LS174T cells, whereas subsequent involvement of platelet
IIb3 integrins converts these transient interactions into
stable adhesion. This wall shear stress level (0.8 dyn/cm2)
corresponds to a shear rate of 100 s1 and an intercellular
contact duration of 1 ms (Bongrand et al., 1988). How-
ever, the rotational streamlines in the cone-and-plate rheo-
meter lead to substantially more frequent intercellular col-
lisions with longer contact times than those occurring in
parallel-flow geometry of the perfusion chamber. Previous
work has shown that for a fixed shear rate the average
contact duration for cell collisions in free-cell suspensions
as modeled by the use of a cone-and-plate rheometer is
25-fold longer than those interactions occurring in a pla-
nar geometry (Bartok and Mason, 1957; Bongrand et al.,
1988). As a first step, we wished to characterize the molec-
ular recognition events involved in platelet-LS174T cell
binding at a shear rate of 800 s1, and a corresponding
intercellular duration of 3 ms. Treating platelets with
thrombin/GPRP-NH2 was shown to augment the recruit-
ment of platelets to the tumor cell surface. Moreover, the
extent of heteroaggregation correlated with platelet P-selec-
tin expression levels in the high shear regime. Blocking
P-selectin or IIb3 integrin function by the use of mAbs
and/or highly specific antagonists also significantly reduced
the extent of platelet-LS174T binding. However, no addi-
tive effect was observed when P-selectin and IIb3 integrin
antagonists were used simultaneously. Selectin-ligand
bonds have been reported to have high tensile strength and
fast molecular association and dissociation rates (Smith et
al., 1999). On the other hand, integrin-ligand bonds cannot
be formed at high shear and corresponding short contact
times in the absence of selectin contribution (Springer,
1995). In light of these observations, our functional data
suggest that both P-selectin and IIb3 integrins are required
to mediate optimal LS174T cell binding in a sequential
manner in the high shear regime.
In marked contrast, platelet-LS174T cell heteroaggrega-
tion at a shear rate of 100 s1, with a corresponding contact
duration of 25 ms, is fundamentally different from the
aforementioned two-step model. More specifically, block-
ade of platelet P-selectin and/or IIb3 integrins had no
effect on these heterotypic adhesive interactions. In accor-
dance with the functional blocking assays, IIb3-deficient
platelets isolated from a GT patient coaggregated with
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LS174T cells as effectively and extensively as did platelets
from normal volunteers. We next examined the potential
involvement of platelet GPIb, because this adhesion recep-
tor has previously been shown to mediate platelet-tumor cell
interactions under static conditions (Oleksowicz et al.,
1995). However, use of a function-blocking anti-GPIb mAb
as well as GPIb-deficient platelets did not exhibit altered
binding to LS174T cells compared with control platelets
from healthy volunteers. Altogether, these data indicate that
platelet P-selectin, IIb3, and GPIb are not likely to be
involved in platelet-LS174T cell heteroaggregation at a
shear rate of 100 s1 corresponding to an intercellular
contact time of 25 ms.
It is noteworthy that the equivalent wall shear rate in a
parallel-plate perfusion system that allows collision dura-
tions in the order of 25 ms is 4 s1, which corresponds
to near static conditions. Ample evidence suggests that
platelet integrins can effectively bind ligand(s) under static
conditions. Moreover, several platelet integrins predomi-
nantly bind to RGD-containing peptide sequences present in
adhesive proteins such as fibrin(ogen) and von Willebrand
factor (Konstantopoulos et al., 1998a). Consequently, we
assessed the potential integrin involvement in this adhesion
process by incubating platelets with RGD-containing pep-
tides before their mixing with LS174T cells in a linear shear
field. Our data indeed indicate that an RGD-, but not a
control RGE-, containing peptide essentially eliminated
platelet-LS174T cell binding at 100 s1. Furthermore, the
counter-receptor on the LS174T cell surface appears to be a
protease-sensitive glycoprotein, as evidenced by abrogation
of the heteroaggregation upon tumor cell treatment with
trypsin. These observations support a model in which plate-
let integrins interact with a trypsin-sensitive epitope(s) on
the LS174T surface in the low shear regime. It is very likely
that fibrin may function as a potential adhesive bridge, as
was recently shown for platelet-melanoma cell interactions
(Biggerstaff et al., 1999). This is supported by our obser-
vations showing that inclusion of thrombin, which increases
the extent of platelet-bound fibrin, and the fibrin polymer-
ization inhibitor GPRP-NH2 in the suspending medium sig-
nificantly potentiates the extent of platelet binding to
LS174T cells. Our data also provide clear evidence for
divalent-cation requirements in this adhesion process, as
evidenced by the abolition of heteroaggregation upon blood
treatment with EDTA. Chelation of divalent-cations may
inhibit integrin-ligand binding as well as platelet activation.
Taken altogether, this work clearly shows that the fluid
mechanical environment of the circulatory system affects
both the kinetics and receptor specificity of activation-
dependent platelet binding to LS174T colon carcinoma
cells. Elucidation of the detailed physical and molecular
basis underlying platelet-colon carcinoma conjugate forma-
tion may provide insights for the rational development of
novel therapeutic strategies aimed to alter these adhesive
interactions.
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